7. Adrenergic responses
Alpha (α) receptors Beta (β) receptors
Rise in BP Fall in BP
Little action on heart, arrhythmia
at high doses
↑ rate, force and conduction
velocity of heart
- Bronchodilation
Mydriasis, decreased aqueous
secretion
No effect on iris, relaxation of
ciliary muscles, enhanced
aqueous secretion
11. Adrenergic drugs: overall actions
Heart
(β1)
• Increases HR
• Activates latent pacemakers – arrhythmia at
higher doses
• Force of contraction, cardiac output and oxygen
consumption- increased
• Increased conduction velocity – may overcome
partial heart block
12. Adrenergic drugs: overall actions
Blood
vessels
• Vasoconstriction (α1 and α2): cutaneous, mucous
membrane, renal beds
• Vasodilation (β2): skeletal muscles, liver, coronaries
• Action more marked in arterioles and precapillary
sphincters
Blood
Pressure
• NA: rise in systolic, diastolic and mean BP (α)
• Iso: rise in systolic BP, marked fall in diastolic BP (β1 &β2)
• Adr: (slow i.v.) rise in systolic, fall in diastolic, mean BP
rises
14. Adrenergic drugs: overall actions
Metabolic
• Causes glycogenolysis: hyperglycaemia,
hyperlactacidemia
• Lipolysis: rise in plasma free fatty acids,
calorigenesis
• Transient hyperkalemia followed by
hypokalemia
15. Adrenaline: Adverse Effects
■ s.c./i.m. injection:
– Transient restlessness, headache, palpitation,
anxiety, tremor and pallor
■ Marked rise in BP leading to CVA,VT/VF, angina
– Large doses or inadvertent i.v. injection of Adr
myocardial infarction
16. Adrenaline: Contraindications
■ Should not be given:
– During general anaesthesia (halothane): risk of
arrhythmia
– Patients receiving β blockers : marked rise in BP
■ Contraindications:
– Hypertension
– Hyperthyroid
– Angina patients
18. Dopamine
■ Dopaminergic (D1 and D2) and adrenergic (α and β1)
agonist
■ Increases g.f.r. and exerts natriuretic effects (D1)
■ Normal doses: raises cardiac output and systolic BP
■ Moderately High Doses: Positive inotropic effect
■ Uses
– Cardiogenic or septic shock
– Severe CHF
19. Dobutamine
■ Derivative of Dopamine
■ Selective β1 agonist
■ Uses-
■ As an inotropic agent in pump failure accompanying:
– Myocardial Infarction
– Cardiac surgery
■ Short term management of severe congestive heart failure
21. Phenylephrine
■ Selective α1 agonist: raises BP due to vasoconstriction
■ Reduces intra-ocular pressure
■ Can be given orally as nasal decongestants
■ Topical uses:
– Nasal decongestants
– Mydriasis without Cycloplegia
■ Side effects:-After congestion seen
22. Nasal Decongestants
■ α agonist- topically produces local vasoconstriction
■ Selective α2 agonists (naphazoline, xylometazoline,
oxymetazoline): longer duration of action
■ Lesser after congestion
■ Side Effects:
– Initial stinging,
– Impairs mucosal ciliary function on prolonged use: atrophic
rhinitis and anosmia;
– Systemic side effects: CNS depression, fall in BP
23. Indications: Vascular Uses
■ Hypotensive states (shock, spinal anaesthesia, hypotensive
drugs)
■ Along with local anaesthetics
■ Control of local bleeding
■ Nasal Decongestants
24. Indications: Cardiac Use
■ Cardiac arrest (drowning, electrocution, etc.)
– In combination with external cardiac massage
■ Partial or complete A-V block
– Isoprenaline as temporary measure
■ Congestive Heart Failure
26. Indications
■ Insulin Hypoglycaemia
■ Nocturnal enuresis in children and urinary incontinence
– Amphetamine
■ Uterine relaxant
– Ritoridine: to postpone labour
– Isosuxprine: threatened abortion and dysmenorrhoea
27. Indications: Central Uses
■ Attention Deficit
Hyperkinetic Disorders
– Amphetamine
■ Narcolepsy
– Amphetamine, Modafinil
– Imipramine like drugs
■ Epilepsy
– Amphetamines
■ Parkinsonism
– Amphetamine
■ Obesity
– Considered in severe
obesity
28. Any queries??
■ Next Topic:
– Overview of Anti-adrenergic drugs
– Drugs used in Glaucoma
■Thank you!!
Editor's Notes
Prejunctional on nerve ending; post-junctional in brain, pancreatic β cells; extra-junctional in some vessels, platelets
Normal doses: raises cardiac output and systolic BP
Moderately High Doses: Positive inotropic effect (direct β1 and D1 action + that due to NA release)
Selective β1 agonist: increased force of cardiac contraction and output
Hypotensive states (shock, spinal anaesthesia, hypotensive drugs)
Along with volume replacement (neurogenic and haemorrhagic shock)
To maintain cerebral perfusion
Not to be used in shock with marked vasoconstriction
Cardiogenic shock: dopamine/dobutamine preferred
Anaphylactic shock: Adrenaline 0.5 mg i.m. stat (benefits bronchospasm and laryngospasm as well)
Autonomic neuropathy: oral ephedrine
Along with local anaesthetics
Infiltration, nerve block, spinal anaesthesia
Prolonged duration of anaesthesia, systemic toxicity of local anaesthetics and local bleeding minimised
Control of local bleeding
Epistaxis, gastric erosions, stress ulcers
Nasal Decongestants
Common colds, rhinitis, blocked nose
Blocked Eustachian tube
Cautious use in infants and young children; hypertensive and elderly males
Narcolepsy
Amphetamine: possibility of development of tolerance, abuse, behavioural abnormalities
Modafinil: less dependent potential
Imipramine like drugs can be used